Krebs Biochemicals & Industries Limited (BOM:524518)

BOM:524518 Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 26, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	941	1,440	1,316	1,216	3,092	1,743
Market Cap Growth	-55.81%	9.46%	8.19%	-60.67%	77.35%	18.25%
Enterprise Value	3,154	3,484	3,193	2,952	4,319	2,560
Last Close Price	43.63	66.79	61.02	56.40	143.40	88.85
PS Ratio	4.09	3.33	2.61	2.33	5.18	3.31
PB Ratio	-0.58	-0.98	-1.10	-1.22	-4.12	-4.08
P/OCF Ratio	-	-	55.63	-	-	-
EV/Sales Ratio	13.70	8.05	6.33	5.66	7.23	4.86
Debt / Equity Ratio	-1.38	-1.45	-1.62	-1.84	-1.91	-2.60
Net Debt / Equity Ratio	-1.38	-1.45	-1.62	-1.84	-1.90	-2.58
Net Debt / EBITDA Ratio	-22.38	-14.34	-22.47	-11.85	-4.23	-6.39
Net Debt / FCF Ratio	-	-18.51	-27.45	-4.60	-3.23	-2.75
Asset Turnover	-	0.25	0.29	0.29	0.34	0.36
Inventory Turnover	-	1.19	0.83	1.45	2.06	3.20
Quick Ratio	0.00	0.00	0.08	0.02	0.01	0.02
Current Ratio	0.09	0.10	0.28	0.33	0.46	0.44
Return on Assets (ROA)	-	-7.66%	-5.38%	-7.49%	-14.14%	-9.45%
Return on Capital Employed (ROCE)	-30.10%	-32.50%	-13.10%	-17.40%	-35.30%	-20.00%
Earnings Yield	-24.30%	-18.71%	-14.99%	-20.31%	-14.40%	-16.27%
FCF Yield	-	-7.95%	-5.36%	-32.79%	-14.33%	-22.99%
Buyback Yield / Dilution	0.03%	-	-	-	-9.89%	-9.00%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.